Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer
- Pablo Perez-Wert 1, Sara Fernandez-Hernandez 2, Angelo Gamez-Pozo 2, Marina Arranz-Alvarez 3, Ismael Ghanem 1, Rocío López-Vacas 2, Mariana Díaz-Almirón 4, Carmen Méndez 5, Juan Ángel Fresno Vara 2,6, Jaime Feliu 1,6,7,8, Lucia Trilla-Fuertes 2, Ana Custodio 1,6
- 1Department of Medical Oncology, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.
- 2Molecular Oncology Laboratory, Institute of Medical and Molecular Genetics-INGEMM, Hospital Universitario La Paz-IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
- 3IdiPAZ Biobank, La Paz University Hospital-IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
- 4Biostatistics Unit, La Paz University Hospital-IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
- 5Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.
- 6Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII (Instituto de Salud Carlos III), 28029 Madrid, Spain.
- 7Cátedra UAM-AMGEN, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
- 8Medicine Department, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
- 0Department of Medical Oncology, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study refines gastric adenocarcinoma (GA) molecular subtypes using multi-layered analysis, identifying new prognostic groups and potential therapeutic targets like Claudin-18 for better patient stratification and personalized treatment.
Area Of Science
- Oncology
- Genomics
- Bioinformatics
Background
- Gastric adenocarcinoma (GA) presents a significant global health challenge with limited clinical utility of current molecular classifications.
- Advancements in treatment have not significantly improved prognosis for many GA patients.
Purpose Of The Study
- To perform a multi-layered functional analysis of TCGA RNA-seq data to refine GA molecular subtypes.
- To explore therapeutic implications and identify novel prognostic markers.
- To improve patient stratification for personalized treatment strategies.
Main Methods
- Reanalysis of TCGA RNA-seq data from 142 localized GA patients treated with adjuvant chemotherapy.
- Application of probabilistic graphical models and recurrent sparse k-means/consensus clustering for layer-based analysis.
- Identification of functional nodes, biological layers, and a combined molecular layer (CML) classification.
Main Results
- Survival differences were observed among TCGA molecular subtypes, with the GS subtype showing the poorest prognosis.
- The CML classification identified three prognostic groups, with CML2 (GS-like) linked to lipid metabolism and worse survival.
- Transcriptomic heterogeneity within the CIN subtype revealed clusters associated with proteolysis and lipid metabolism, including a novel CIN-MSI-like subset.
- Claudin-18 was found to be overexpressed across subtypes, indicating its potential as a therapeutic target.
Conclusions
- This study enhances the understanding of GA biology, enabling more refined patient stratification.
- The findings suggest Claudin-18 as a potential therapeutic target for gastric adenocarcinoma.
- Further research is necessary to translate these molecular insights into clinical practice for personalized GA treatment.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
03:21
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
02:24
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

